Mergers and Acquisitions

Our attorneys provide in-depth deal advice, from initial structuring through due diligence, negotiation, and documentation to closing and post-closing integration across numerous industries.

In every transaction, business perspective informs our legal strategy and creative issue resolution so that client goals are met with outcomes that pave the way for growth and success.

Our M&A attorneys represent buyers and sellers of all sizes, ranging from small, privately held companies to multinational public companies and private equity funds in transactions that span the lower-middle and middle markets to multi-billion dollar mergers. The scale of our practice and depth of our deal experience enable us to provide cost-effective, focused solutions that meet the unique requirements of every client and transaction, no matter the deal type, company size, or industry.

Our clients' objectives are at the center of every engagement, whether we are advising Fortune 500 companies in implementing strategic growth initiatives through M&A, negotiating an add-on acquisition of a private equity portfolio company or counseling family-owned businesses in executing exit strategies.

We frequently advise clients on cross-border transactions, collaborating with existing client resources in local jurisdictions or our relationships with a host of international firms that are established leaders in their markets.

Representative Experience

Advised DuPont de Nemours, Inc. in numerous transactions, including:
- the divestiture of its Mobility & Materials segment to a technology and special materials company for a purchase price of $11 billion;
- the negotiation of hundreds of manufacturing, supply, and service agreements in transformative transactions, including the sale of 80% ownership interest of its Delrin business valued at $1.8 billion, the merger of IFF and DuPont’s Nutrition & Biosciences business in a Reverse Morris Trust transaction, and the separation of DowDuPont into three separate publicly traded companies;
- acquiring Donatelle Plastics, a medical device contract manufacturer, for over $500 million; and
- the $510 million sale of its Clean Technologies business.
Represented ShoreView Industries, a private equity firm, in:
- completing ten add-on transactions and one divestiture in 2023 for existing portfolio companies;
- the sale of portfolio company Burton Plumbing LLC following six acquisitions in less than two years; and
- investments in current portfolio companies: Crown Products, Inc., 8020 Consulting, LLC, and Diversified Search Group.
Represented leading wireless products supplier TESSCO Technologies Inc. in its merger with two entities affiliated with Lee Equity Partners and Twin Point Capital in a transaction valued $161.4 million.
Represented Republic Services, Inc., the second largest provider of waste disposal, recycling, and environmental services in the United States, on hundreds of M&A transactions throughout the country, including acquisitions, divestitures, and joint venture transactions.
Represented the Minnesota Timberwolves Limited Partnership in the sale of ownership interests by Taylor Corporation in a transaction, approved by the NBA, valued at $1.5 billion.
Represented an owner in the sale of a portion of its interest in The Phillies to a new investor.

Represented Eurofins Scientific in the purchase of Ascend Clinical, a renal and transplant testing lab testing company.
Represented Aramark in the acquisition of Adventures on the Gorge, an outdoor adventure resort.
Represented Hub International Limited in a series of acquisitions of insurance brokerage, employee benefits, and retirement and wealth management providers across the country.
Represented Wealth Enhancement Group, a serial acquirer of financial advising and wealth management firms, in the acquisition of assets to expand their growing presence in various states, including Minnesota, California, Nevada, New York, New Jersey, Iowa, Virginia, Georgia, Massachusetts, and Colorado.
Represented ProFusion Industries, LLC, a film and plastic manufacturer, in its sale to a private equity firm.
Represented IVEST Consumer Partners in its acquisition of Cloudco, LLC, a company that licenses brands for consumer products and content.
Represented Cimarron Label and Western Printing in a stock acquisition by Inovar Packaging Group, LLC, a national packaging production company that supplies leading brands across several industries.
Represented medical device manufacturer RhythMedix in sale of majority stake to Pharos Capital Group, LLC, a health care industry-focused private equity firm.
Represented Visible Supply Chain Management in its $838 million acquisition by integrated container logistics company A.P Moller-Maersk, the world’s largest container shipping and vessel operator.
Advised Spark Therapeutics in the company’s exclusive collaboration and licensing agreement with CombiGene AB, a Swedish gene therapy development company, for CombiGene’s CG01 project, an investigational gene therapy that aims to treat drug-resistant focal epilepsy.
Represented Communications Systems, Inc. in a series of strategic transformative transactions, including its acquisition by merger with Pineapple Energy, owner of a portfolio of brands including Hawaii Energy Connection, E-Gear, Sungevity, and Horizon Solar Power that provide homeowners with an end-to-end product offering spanning solar, battery storage, and grid services.
Represented global market research, consulting, and M&A advisory firm Ducker Holdings LLC., a portfolio company of Boathouse Capital, in its merger with Carlisle & Company.
Advised Boathouse Capital in the structured fund’s growth investment in Stravos Education LLC, an educational holding company with a portfolio of firms throughout the United States and U.K.
Represented Greystone in the purchase of C-III Asset Management LLC and in the purchase of the general partner of a publicly traded partnership that invests in tax-exempt financings for the housing industry.
Represented Upsher-Smith Laboratories in its sale from parent, ACOVA, Inc., to Japan-based Sawai Pharmaceutical Co. Ltd. in an equity interest deal valued at $1.05 billion and the sale of assets of two branded pharmaceutical products for the treatment of migraines.

Ballard Spahr Advises RhythMedix on Sale of Majority Stake to Pharos Capital Group

People

View All People in this Practice

Share

Representative Experience

Ballard Spahr Advises RhythMedix on Sale of Majority Stake to Pharos Capital Group

People

Rankings and Recognition

Insights, News, and Events

Bridging Campuses: Legal Insights on Education Industry Consolidation – Mergers, Acquisitions, and Antitrust

Ballard Spahr Represents Oxygen Service Company in Partnership With Meritus Gas Partners

The Power List: Mergers & Acquisitions - Barbara Rummel

The Power List: Mergers & Acquisitions - Neal Rasmussen

Related Areas

Contacts